Aktis Oncology, Inc. — Institutional Ownership
Which tracked institutions hold AKTS, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
12
Funds holding
$96437655
Total value held
Buying
12 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $37785952 | 2112127 | — | NEW BUY |
| 2 | Janus Henderson Group Plc | $26022437 | 1454267 | — | NEW BUY |
| 3 | Merck & Co., Inc. | $17046379 | 952844 | — | NEW BUY |
| 4 | State Street Corp | $7661446 | 428253 | — | NEW BUY |
| 5 | Northern Trust Corp | $2674125 | 149476 | — | NEW BUY |
| 6 | Ameriprise Financial Inc | $1841329 | 102925 | — | NEW BUY |
| 7 | Bank Of America Corp /De/ | $1250976 | 69926 | — | NEW BUY |
| 8 | Bank Of New York Mellon Corp | $767498 | 42901 | — | NEW BUY |
| 9 | Morgan Stanley | $549634 | 30723 | — | NEW BUY |
| 10 | Goldman Sachs Group Inc | $539616 | 30163 | — | NEW BUY |
| 11 | Barclays Plc | $173963 | 9724 | — | NEW BUY |
| 12 | Pnc Financial Services Group, Inc. | $124300 | 6948 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.